ropivacaine has been researched along with paxilline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Peng, X; Zhang, Y; Zheng, Q | 1 |
1 other study(ies) available for ropivacaine and paxilline
Article | Year |
---|---|
Ropivacaine inhibits the migration of esophageal cancer cells via sodium-channel-independent but prenylation-dependent inhibition of Rac1/JNK/paxillin/FAK.
Topics: Amides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Esophageal Neoplasms; Focal Adhesion Protein-Tyrosine Kinases; Humans; MAP Kinase Signaling System; Paxillin; Prenylation; rac1 GTP-Binding Protein; ras Proteins; rhoA GTP-Binding Protein; Ropivacaine; Sodium Channels | 2018 |